Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration.
Journal
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
13
06
2022
accepted:
09
11
2022
revised:
07
11
2022
pubmed:
2
12
2022
medline:
24
1
2023
entrez:
1
12
2022
Statut:
ppublish
Résumé
Elevated brain glutamate has been implicated in non-response to antipsychotic medication in schizophrenia. Biomarkers that can accurately predict antipsychotic non-response from the first episode of psychosis (FEP) could allow stratification of patients; for example, patients predicted not to respond to standard antipsychotics could be fast-tracked to clozapine. Using proton magnetic resonance spectroscopy (
Identifiants
pubmed: 36456813
doi: 10.1038/s41386-022-01508-w
pii: 10.1038/s41386-022-01508-w
pmc: PMC9852590
doi:
Substances chimiques
Glutamic Acid
3KX376GY7L
Antipsychotic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
567-575Subventions
Organisme : Medical Research Council
ID : MC_PC_19041
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N027078/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U120097115
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N026063/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L011794/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0700995
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V013734/1
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
Front Psychiatry. 2017 Apr 28;8:66
pubmed: 28503156
Neuropsychopharmacology. 2014 Mar;39(4):1020-30
pubmed: 24165885
Lancet. 2008 Mar 29;371(9618):1085-97
pubmed: 18374841
Schizophr Bull. 2021 Apr 29;47(3):662-671
pubmed: 33398325
Hum Brain Mapp. 2022 Jun 15;43(9):2833-2844
pubmed: 35234321
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Nat Rev Neurosci. 2005 Jul;6(7):533-44
pubmed: 15995724
Biol Psychiatry. 2018 Mar 15;83(6):475-483
pubmed: 29132653
Magn Reson Med. 2019 Aug;82(2):527-550
pubmed: 30919510
Neuroimage Clin. 2021;30:102631
pubmed: 33799270
BMC Psychiatry. 2017 Jan 13;17(1):12
pubmed: 28086761
Neuropsychiatr Dis Treat. 2012;8:119-22
pubmed: 22536067
Eur J Health Econ. 2019 Dec;20(9):1425-1435
pubmed: 31463768
Neuropsychopharmacology. 2009 Dec;34(13):2675-90
pubmed: 19675535
Mol Psychiatry. 2022 Jan;27(1):744-757
pubmed: 34584230
Mol Psychiatry. 2020 Aug;25(8):1640-1650
pubmed: 32205866
Lancet Psychiatry. 2018 Oct;5(10):797-807
pubmed: 30115598
Schizophr Res. 2020 Jan;215:337-343
pubmed: 31522869
Lancet Psychiatry. 2016 Oct;3(10):935-946
pubmed: 27569526
Front Psychiatry. 2021 Jul 28;12:681419
pubmed: 34393848
Psychiatry Res. 1997 Nov 28;76(1):51-61
pubmed: 9498309
Schizophr Res. 2008 Jul;102(1-3):230-40
pubmed: 18423985
Psychol Med. 2022 Jan;52(1):1-13
pubmed: 36415088
Schizophr Res. 2009 Dec;115(2-3):97-103
pubmed: 19819114
Am J Psychiatry. 2016 Jan;173(1):69-77
pubmed: 26315980
JAMA Psychiatry. 2021 Jun 1;78(6):667-681
pubmed: 33881460
Schizophr Bull. 2021 Mar 16;47(2):505-516
pubmed: 32910150
NMR Biomed. 2021 May;34(5):e4484
pubmed: 33559967
J Psychopharmacol. 2018 May;32(5):497-508
pubmed: 29368979
Am J Psychiatry. 2017 Mar 1;174(3):216-229
pubmed: 27919182
JAMA Psychiatry. 2016 Jul 1;73(7):665-74
pubmed: 27304221
Magn Reson Med. 1993 Dec;30(6):672-9
pubmed: 8139448
Am J Psychiatry. 2005 Mar;162(3):441-9
pubmed: 15741458
J Neurosci. 2013 Jul 31;33(31):12698-704
pubmed: 23904606
NPJ Schizophr. 2019 Aug 1;5(1):12
pubmed: 31371817
Psychol Med. 2021 Feb;51(3):376-386
pubmed: 33602358
Front Psychiatry. 2020 Oct 23;11:553269
pubmed: 33192666
Br J Psychiatry. 2007 Oct;191:325-34
pubmed: 17906243
Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 8;113:110473
pubmed: 34748864
Transl Psychiatry. 2020 Jan 21;10(1):15
pubmed: 32066680
Neuropsychopharmacology. 2012 Oct;37(11):2515-21
pubmed: 22763619
JAMA Psychiatry. 2013 Oct;70(10):1057-66
pubmed: 23966023
Psychol Med. 2020 Oct;50(13):2182-2193
pubmed: 31524118
Neuropsychopharmacology. 2020 Mar;45(4):632-640
pubmed: 31842203
Psychiatry Res. 2011 May 15;187(1-2):42-8
pubmed: 21168920
Biol Psychiatry. 2019 Apr 1;85(7):596-605
pubmed: 30389132
Biol Psychiatry. 2014 Mar 1;75(5):e11-3
pubmed: 23890739
Neuropsychopharmacology. 2007 Sep;32(9):1903-10
pubmed: 17287825
Mol Psychiatry. 2018 Nov;23(11):2145-2155
pubmed: 29880882
Magn Reson Med. 1993 Oct;30(4):424-37
pubmed: 8255190
Curr Med Res Opin. 1997;14(1):1-20
pubmed: 9524789
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):253-8
pubmed: 12506194
Arch Gen Psychiatry. 2005 Sep;62(9):975-83
pubmed: 16143729
Psychol Med. 2016 Nov;46(15):3231-3240
pubmed: 27605254
Schizophr Bull. 2016 May;42(3):744-52
pubmed: 26683625
Schizophr Res. 2019 Aug;210:239-244
pubmed: 30630705
Magn Reson Med. 2006 Jun;55(6):1219-26
pubmed: 16688703
J Clin Psychopharmacol. 2010 Apr;30(2):176-80
pubmed: 20520291
Schizophr Bull Open. 2021 Feb 02;2(1):sgaa072
pubmed: 34746793
Int J Neuropsychopharmacol. 2015 Jan 20;18(6):
pubmed: 25603859
J Proteome Res. 2009 Apr;8(4):1943-52
pubmed: 19714815
BMJ. 1996 Feb 10;312(7027):345-9
pubmed: 8611831
Schizophr Res. 2020 Aug;222:122-132
pubmed: 32505446
Mol Psychiatry. 2019 Oct;24(10):1502-1512
pubmed: 29679071